ENOV - Enovis - Stock Price & Dividends

Enovis Corporation is a medical technology company that develops and provides innovative solutions to improve patient outcomes worldwide. The company's product portfolio includes a range of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy.

Enovis operates through two main segments: Prevention and Recovery, and Reconstructive. The Prevention and Recovery segment offers a comprehensive range of orthopedic solutions and recovery sciences, including orthopedic bracing, hot and cold therapy, bone growth stimulators, and compression garments. These products are designed to help healthcare professionals, such as orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, and athletic trainers, provide effective treatment and care to their patients.

The Reconstructive segment focuses on surgical implant products, including a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. This segment also offers surgical productivity tools to support surgeons and healthcare professionals in performing complex surgical procedures.

Enovis distributes its products through a network of independent distributors and directly under the ESAB and DJO brands. The company's commitment to innovation, quality, and customer satisfaction has enabled it to establish a strong presence in the global medical technology market.

Headquartered in Wilmington, Delaware, Enovis Corporation was founded in 1995 and has since grown into a leading player in the medical technology industry. For more information, please visit the company's website at https://www.enovis.com.